Project Details
Description
Phase I Study of Midazolam Pharmacokinetics, Pharmacodynamics and Adverse Effect following Intramuscular Injection in Dogs using an Autoinjector
Status | Finished |
---|---|
Effective start/end date | 7/1/20 → 6/30/21 |
Funding
- MESAGREEN PHARMACEUTICAL COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.